Pricing Log in Create free account

Aura Biosciences, Inc. (AURA) vs Gyre Therapeutics, Inc. (GYRE)

Aura Biosciences, Inc. and Gyre Therapeutics, Inc. are both Biotechnology companies. Aura Biosciences, Inc. and Gyre Therapeutics, Inc. are of similar size ($678.6M and $657.5M). Aura Biosciences, Inc. has the higher net margin (0.00% vs −13.7%) and the higher return on invested capital (0.00% vs −8.51%). Across the 13 metrics below, Aura Biosciences, Inc. leads on 7 and Gyre Therapeutics, Inc. on 6.

Valuation

Metric AURA GYRE Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5.26 9.71
P/B 1.84 4.29 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 4.66 9.21
Earnings yield (28.69%) (3.29%) (33.15%)
Free cash flow yield (17.86%) (1.16%) (25.50%)

Profitability

Metric AURA GYRE Biotechnology median
Gross margin 0.00% 94.15% 65.16%
Operating margin 0.00% (10.53%) 0.00%
Net margin 0.00% (13.73%) 0.00%
Free cash flow margin 0.00% (6.12%) 0.00%
Return on equity (53.49%) (11.75%) (56.36%)
Return on assets (47.42%) (9.08%) (48.04%)
Return on invested capital 0.00% (8.51%) 0.00%

Growth

Metric AURA GYRE Biotechnology median
Revenue growth (TTM) — 10.72% 6.02%
EPS growth (last fiscal year) (0.57%) (60.00%) 30.26%
Revenue growth, 5-year CAGR — 40.96% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AURA GYRE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.82 4.26 4.72
Net debt to EBITDA 1.29 (3.74) 0.96

Dividend

Metric AURA GYRE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AURA GYRE Biotechnology median
Market cap 657.49m 678.62m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack